Quest Diagnostics saw a higher recovery in the company’s testing volumes in the United States where state and local governments were slowly lifting restrictions after the coronavirus lockdowns.
Siemens Healthineers stands ready to ramp up production of the company’s antibody test to more than 50 million per month from June 2020 as governments across the world are keen to identify those who may have developed immunity to the coronavirus.
As the world battles the COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2, biopharma and biotech companies are approaching the fight with various weapons – repurposed drugs, antivirals, vaccines and clinical antibodies. One of the companies deeply involved in clinical antibody development against COVID-19 is San Diego-based Sorrento Therapeutics.
Britain is in talks with Swiss drugmaker Roche Holding AG to buy an accurate COVID-19 antibody test, following the lead of the European Union and United States, which had already given preliminary approval to the tests.
Thermo Fisher Scientific Inc. expanded the company’s response to the COVID-19 pandemic by developing a total antibodies test in collaboration with WuXi Diagnostics and Mayo Clinic.
Abbott Laboratories’ antibody test for the new coronavirus is highly likely to correctly determine whether people have ever been infected with the fast-spreading virus, the company said, citing a U.S. study.
Roche won emergency approval from the U.S. Food and Drug Administration in for an antibody test to determine whether people have ever been infected with the coronavirus.
Swiss pharma giant Roche joined the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease.
The U.S. Food and Drug Administration granted Ortho Clinical Diagnostics’ total antibody assay for COVID-19 Emergency Use Authorization.
While the world waits for a vaccine against SARS-CoV-2 – the novel coronavirus that causes COVID-19 – one likely control and exit strategy is testing for immunity, or an antibody test.
